Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea

PurposePheochromocytoma (PCC) and paraganglioma (PGL) (PPGL) are rare neuroendocrine tumors, and data on managing these conditions in children and adolescents are lacking. The objective of this study was to demonstrate the clinical presentation and treatment outcomes in children and adolescents with...

Full description

Bibliographic Details
Main Authors: Hyojung Park, Min-Sun Kim, Jiwon Lee, Jung-Han Kim, Byong Chang Jeong, Sanghoon Lee, Suk-Koo Lee, Sung Yoon Cho, Dong-Kyu Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2020.610746/full
_version_ 1818558794475503616
author Hyojung Park
Min-Sun Kim
Jiwon Lee
Jung-Han Kim
Byong Chang Jeong
Sanghoon Lee
Suk-Koo Lee
Sung Yoon Cho
Dong-Kyu Jin
author_facet Hyojung Park
Min-Sun Kim
Jiwon Lee
Jung-Han Kim
Byong Chang Jeong
Sanghoon Lee
Suk-Koo Lee
Sung Yoon Cho
Dong-Kyu Jin
author_sort Hyojung Park
collection DOAJ
description PurposePheochromocytoma (PCC) and paraganglioma (PGL) (PPGL) are rare neuroendocrine tumors, and data on managing these conditions in children and adolescents are lacking. The objective of this study was to demonstrate the clinical presentation and treatment outcomes in children and adolescents with PPGL in a single tertiary care center in Korea.MethodsThis retrospective study included 23 patients diagnosed with PCC (n = 14) and PGL (n = 9) before the age of 21 at Samsung Medical Center (from June 1994 to June 2019). We describe age, gender, family history, clinical characteristics, laboratory findings, pathologic findings, therapeutic approaches, and treatment outcomes.ResultsOf the 23 patients, 14 had PCC and nine had PGL. The median age at diagnosis was 16.8 years (range, 6.8–20.8 years). The common presenting symptoms were hypertension (n = 10), headache (n = 9), palpitation (n = 4), and sweating (n = 4). The plasma or 24-hour urine catecholamine and/or metabolite concentrations were markedly elevated in 22 patients with PPGL, but were normal in one patient with carotid body PGL. All tumors were visualized on computed tomography. Genetic tests were performed in 15 patients, and seven patients showed mutations in RET (n = 3), SDHB (n = 3), and VHL (n = 1). All patients underwent surgery, and complete excision was performed successfully. Three patients with metastasis underwent postoperative adjuvant therapy.ConclusionThis study suggests that pediatric PPGL tends to be extra-adrenal and bilateral and shows a higher potential for genetic mutations. Considering the hereditary predisposition of pediatric PPGL, genetic screening tests are strongly recommended, and lifelong follow-up is needed to detect recurrence and metastasis. Further research with a larger sample size and routine genetic screening is needed to better understand the genetic conditions and long-term prognosis of PPGL.
first_indexed 2024-12-14T00:16:56Z
format Article
id doaj.art-496b575e247842ac8e72eca9b04cd23d
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-14T00:16:56Z
publishDate 2021-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-496b575e247842ac8e72eca9b04cd23d2022-12-21T23:25:27ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-01-011110.3389/fendo.2020.610746610746Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in KoreaHyojung Park0Min-Sun Kim1Jiwon Lee2Jung-Han Kim3Byong Chang Jeong4Sanghoon Lee5Suk-Koo Lee6Sung Yoon Cho7Dong-Kyu Jin8Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaDepartment of Pediatric Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaDepartment of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaDepartment of Pediatric Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaDepartment of Pediatric Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaPurposePheochromocytoma (PCC) and paraganglioma (PGL) (PPGL) are rare neuroendocrine tumors, and data on managing these conditions in children and adolescents are lacking. The objective of this study was to demonstrate the clinical presentation and treatment outcomes in children and adolescents with PPGL in a single tertiary care center in Korea.MethodsThis retrospective study included 23 patients diagnosed with PCC (n = 14) and PGL (n = 9) before the age of 21 at Samsung Medical Center (from June 1994 to June 2019). We describe age, gender, family history, clinical characteristics, laboratory findings, pathologic findings, therapeutic approaches, and treatment outcomes.ResultsOf the 23 patients, 14 had PCC and nine had PGL. The median age at diagnosis was 16.8 years (range, 6.8–20.8 years). The common presenting symptoms were hypertension (n = 10), headache (n = 9), palpitation (n = 4), and sweating (n = 4). The plasma or 24-hour urine catecholamine and/or metabolite concentrations were markedly elevated in 22 patients with PPGL, but were normal in one patient with carotid body PGL. All tumors were visualized on computed tomography. Genetic tests were performed in 15 patients, and seven patients showed mutations in RET (n = 3), SDHB (n = 3), and VHL (n = 1). All patients underwent surgery, and complete excision was performed successfully. Three patients with metastasis underwent postoperative adjuvant therapy.ConclusionThis study suggests that pediatric PPGL tends to be extra-adrenal and bilateral and shows a higher potential for genetic mutations. Considering the hereditary predisposition of pediatric PPGL, genetic screening tests are strongly recommended, and lifelong follow-up is needed to detect recurrence and metastasis. Further research with a larger sample size and routine genetic screening is needed to better understand the genetic conditions and long-term prognosis of PPGL.https://www.frontiersin.org/articles/10.3389/fendo.2020.610746/fullpheochromocytomaparagangliomaadrenal masshypertensionpediatrics
spellingShingle Hyojung Park
Min-Sun Kim
Jiwon Lee
Jung-Han Kim
Byong Chang Jeong
Sanghoon Lee
Suk-Koo Lee
Sung Yoon Cho
Dong-Kyu Jin
Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea
Frontiers in Endocrinology
pheochromocytoma
paraganglioma
adrenal mass
hypertension
pediatrics
title Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea
title_full Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea
title_fullStr Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea
title_full_unstemmed Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea
title_short Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea
title_sort clinical presentation and treatment outcomes of children and adolescents with pheochromocytoma and paraganglioma in a single center in korea
topic pheochromocytoma
paraganglioma
adrenal mass
hypertension
pediatrics
url https://www.frontiersin.org/articles/10.3389/fendo.2020.610746/full
work_keys_str_mv AT hyojungpark clinicalpresentationandtreatmentoutcomesofchildrenandadolescentswithpheochromocytomaandparagangliomainasinglecenterinkorea
AT minsunkim clinicalpresentationandtreatmentoutcomesofchildrenandadolescentswithpheochromocytomaandparagangliomainasinglecenterinkorea
AT jiwonlee clinicalpresentationandtreatmentoutcomesofchildrenandadolescentswithpheochromocytomaandparagangliomainasinglecenterinkorea
AT junghankim clinicalpresentationandtreatmentoutcomesofchildrenandadolescentswithpheochromocytomaandparagangliomainasinglecenterinkorea
AT byongchangjeong clinicalpresentationandtreatmentoutcomesofchildrenandadolescentswithpheochromocytomaandparagangliomainasinglecenterinkorea
AT sanghoonlee clinicalpresentationandtreatmentoutcomesofchildrenandadolescentswithpheochromocytomaandparagangliomainasinglecenterinkorea
AT sukkoolee clinicalpresentationandtreatmentoutcomesofchildrenandadolescentswithpheochromocytomaandparagangliomainasinglecenterinkorea
AT sungyooncho clinicalpresentationandtreatmentoutcomesofchildrenandadolescentswithpheochromocytomaandparagangliomainasinglecenterinkorea
AT dongkyujin clinicalpresentationandtreatmentoutcomesofchildrenandadolescentswithpheochromocytomaandparagangliomainasinglecenterinkorea